Suppr超能文献

外科 ICU 患者肝素诱导的血小板减少症的过度诊断。

Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.

机构信息

Department of Surgery, Division of Trauma and Surgical Critical Care, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

J Am Coll Surg. 2011 Jul;213(1):10-7; discussion 17-8. doi: 10.1016/j.jamcollsurg.2011.04.002. Epub 2011 May 4.

Abstract

BACKGROUND

Heparin use in surgical patients places them at increased risk for developing heparin-induced thrombocytopenia (HIT). The false positive rate of HIT using the current standard criteria is unknown in surgical ICU patients, who often have confounding factors that cause thrombocytopenia.

STUDY DESIGN

Surgical ICU patients, admitted over a 2-year period with a positive screening test for HIT (platelet factor [PF] 4 ≥ 0.4 optical density [OD]), were reviewed retrospectively at a single institution. Correlation of the Warkentin 4-T score and commercial heparin PF4 ELISA with serotonin releasing assay (SRA) was performed. Logistic regression was used to determine independent risk factors associated with the development of HIT.

RESULTS

PF4 tests were requested in 643 patients based on a clinical suspicion of HIT. Of these, 104 patients had a PF4 result, an SRA value (%), and a 4-T score available. Twenty patients (19%) had true positive HIT, defined as a positive PF4 and positive SRA (SRA ≥ 20%). Eighty-four patients (81%) were false positive, defined as a positive PF4 and negative SRA. Five of 58 patients with Warkentin score of 0 to 3, and 6 of 14 patients with Warkentin score of 6 to 8 were HIT positive by SRA.

CONCLUSIONS

In surgical ICU patients, clinical suspicion for HIT necessitates PF4 and SRA analysis. Testing for HIT or treatment with a direct thrombin inhibitor should not depend on the Warkentin 4-T score alone. Although a PF4 ≥ 0.4 OD is considered a positive screening test for HIT, a PF4 ≥ 2.0 OD is preferable in surgical ICU patients.

摘要

背景

在接受肝素治疗的手术患者中,肝素诱导的血小板减少症(HIT)的风险增加。在经常存在导致血小板减少症的混杂因素的外科重症监护病房(SICU)患者中,目前标准检测 HIT 的假阳性率尚不清楚。

研究设计

回顾性分析了一家医院 2 年内收治的 HIT 筛查试验(血小板因子[PF]4≥0.4 光密度[OD])阳性的 SICU 患者。对 Warkentin 4-T 评分和商用肝素 PF4 ELISA 与血清素释放试验(SRA)进行了相关性分析。采用逻辑回归分析确定与 HIT 发生相关的独立危险因素。

结果

根据对 HIT 的临床怀疑,有 643 例患者进行了 PF4 检测。其中,104 例患者的 PF4 结果、SRA 值(%)和 4-T 评分可用。20 例(19%)患者的 HIT 检测结果为真阳性,定义为 PF4 和 SRA 均阳性(SRA≥20%)。84 例(81%)患者的 HIT 检测结果为假阳性,定义为 PF4 阳性而 SRA 阴性。Warkentin 评分 0-3 的 58 例患者中有 5 例,Warkentin 评分 6-8 的 14 例患者中有 6 例 SRA 阳性。

结论

在外科 SICU 患者中,对 HIT 的临床怀疑需要进行 PF4 和 SRA 分析。检测 HIT 或使用直接凝血酶抑制剂治疗不应仅依赖 Warkentin 4-T 评分。虽然 PF4≥0.4 OD 被认为是 HIT 的阳性筛查试验,但在外科 SICU 患者中,PF4≥2.0 OD 更为理想。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验